Target intelligence / Profile preview

Qi and Blood Stagnation

Molecular classification
Other
01

Overview

Qi and Blood Stagnation is a fundamental pathological syndrome in Traditional Chinese Medicine (TCM) rather than a specific molecular target such as a receptor or enzyme. It characterizes a state where the flow of 'Qi' (vital energy) is obstructed, which subsequently fails to promote healthy blood circulation, leading to 'Blood Stasis' (Xue Yu). Modern scientific investigations correlate this syndrome with physiological conditions including blood hyperviscosity, impaired microcirculation, vascular endothelial dysfunction, and chronic inflammation (PMID: 31102941, 28834469). As a systemic syndrome pattern, it is not classified under a single molecular family but is often managed using multi-component herbal therapies that target various pathways simultaneously. Common therapeutic interventions, such as Salvia miltiorrhiza, work by inhibiting platelet activation and improving blood flow via the modulation of nitric oxide signaling and inflammatory cytokines. In the context of drug development, it represents a complex phenotype rather than a single targetable protein, making it a focus of integrative medicine research for cardiovascular and oncological conditions (PMID: 25705353).

Other names
Qi stagnation and blood stasisQi-Zhi-Xue-YuStagnation of Qi and BloodBlood stasis syndrome
02

Mechanism of action

Regulation of hemodynamics, inhibition of platelet aggregation, anti-inflammatory activity, improvement of microcirculation, and modulation of the coagulation cascade.

03

Biological functions

CirculationHemostasisInflammationMetabolismVascular tone regulation
04

Disease associations

Cardiovascular diseaseCancerCerebrovascular diseaseChronic painGynecological disorders
05

Safety considerations

Increased risk of bleedingDrug-herb interactions with anticoagulantsLack of standardized molecular diagnostic criteriaPotential for hepatotoxicity in certain multi-herb formulations
06

Interacting drugs

Salvia miltiorrhiza (Danshen)

6 more in the full profile.

07

Biomarkers

Blood viscosityD-dimerFibrinogen levelsPlatelet aggregation rateC-reactive protein (CRP)

Beyond the preview

Go deeper on Qi and Blood Stagnation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qi and Blood Stagnation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call